Doctor profile · Federal record
Dr. Christopher Bettacchi, MD
Infectious Disease Physician (CMS: Infectious Disease) · Hospitalist Physician · Dallas, TX
- NPI 1083669543
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 25 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3409 Worth St Suite 710
Dallas, TX 752462060
(214) 823-2533
fax (214) 824-8679 - Mailing address
-
3409 Worth St Ste 710
Dallas, TX 752462060
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- July 21, 2010
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207RI0200X — NUCC code
- State licenses (2)
- Texas #N6174 · Alabama #26675
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1083669543. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
40,635
Distinct HCPCS
10
Medicare allowed
$871,938
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 25,740 | 256 | $23 | |
J0878 |
Injection, daptomycin, 1 mg | 11,200 | 14 | $0 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 1,206 | 326 | $79 | |
96372 |
Injection of drug or substance under skin or into muscle | 600 | 273 | $14 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 427 | 166 | $105 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 308 | 93 | $65 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 234 | 78 | $117 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 219 | 194 | $173 | |
J3489 |
Injection, zoledronic acid, 1 mg | 210 | 42 | $9 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 115 | 24 | $133 |
In context: peer comparison
Among 36 peers in this city , average services per provider: 1,026. This provider delivers 40× the peer median.Open Payments
Industry payments received
All-time total
$42,010
Transactions
143
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ViiV Healthcare Company | 80 | $36,021.89 | |
| Merck Sharp & Dohme LLC | 9 | $4,164.20 | |
| Gilead Sciences, Inc. | 15 | $934.51 | |
| Insmed, Inc. | 9 | $230.93 | |
| ABBVIE INC. | 8 | $200.90 | |
| Shionogi Inc | 7 | $115.98 | |
| Napo Pharmaceuticals Inc | 4 | $85.38 | |
| Ferring Pharmaceuticals Inc. | 2 | $64.67 | |
| HOSPIRA, INC. | 3 | $52.94 | |
| EMD Serono, Inc. | 2 | $52.14 | |
| Janssen Pharmaceuticals, Inc | 2 | $42.22 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25.37 | |
| Astellas Pharma US Inc | 1 | $18.60 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,501
Patients
192
Total drug cost
$1,697,325
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Daptomycin | Generic | 425 | 70 | $418,089 |
| Ertapenem (Ertapenem Sodium) | Brand | 244 | 42 | $160,377 |
| Ceftriaxone (Ceftriaxone Sodium) | Brand | 194 | 36 | $57,753 |
| Biktarvy (Bictegrav/Emtricit/Tenofov Ala) | Brand | 110 | 0 | $447,699 |
| Triumeq (Abacavir/Dolutegravir/Lamivudi) | Brand | 94 | 0 | $351,512 |
| Cefepime Hcl | Generic | 74 | 18 | $14,718 |
| Minocycline Hcl | Generic | 73 | 26 | $4,339 |
| Meropenem | Generic | 47 | 0 | $16,441 |
| Dovato (Dolutegravir Sodium/Lamivudine) | Brand | 40 | 0 | $117,139 |
| Fosfomycin Tromethamine | Generic | 36 | 0 | $11,908 |
Hospital affiliations
Frequently asked questions
What is Dr. Christopher Bettacchi's medical specialty?
Dr. Christopher Bettacchi practices Infectious Disease Physician in Dallas, TX.
Where does Dr. Christopher Bettacchi practice?
Dr. Christopher Bettacchi practices at 3409 Worth St Suite 710, Dallas, TX 752462060. Office phone: 2148232533.
What is Dr. Christopher Bettacchi's NPI?
Dr. Christopher Bettacchi's National Provider Identifier (NPI) is 1083669543, issued by NPPES.
Does Dr. Christopher Bettacchi accept Medicare assignment?
Yes. Dr. Christopher Bettacchi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Christopher Bettacchi commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Injection, daptomycin, 1 mg (HCPCS J0878); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232). Source: CMS Medicare Physician & Other Practitioners file.